Unveiling racial disparities in prostate cancer using an integrative genomic and transcriptomic analysis

Prostate cancer exhibits significant racial disparities, with African American (AA) individuals showing ∼64% higher incidence and 2.3 times greater mortality rates compared to their Caucasian (CA) counterparts. Understanding the complex interplay of genetic, environmental, lifestyle, socioeconomic,...

Full description

Saved in:
Bibliographic Details
Main Authors: Abdalla Elbialy, Akshay Sood, Shang-Jui Wang, Peng Wang, Ahmed Fadiel, Anil V. Parwani, Steven Huang, Gennady Shvets, Nagireddy Putluri, Jenny Li, Xuefeng Liu
Format: Article
Language:English
Published: Elsevier 2025-04-01
Series:Cell Insight
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2772892725000124
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850187780189061120
author Abdalla Elbialy
Akshay Sood
Shang-Jui Wang
Peng Wang
Ahmed Fadiel
Anil V. Parwani
Steven Huang
Gennady Shvets
Nagireddy Putluri
Jenny Li
Xuefeng Liu
author_facet Abdalla Elbialy
Akshay Sood
Shang-Jui Wang
Peng Wang
Ahmed Fadiel
Anil V. Parwani
Steven Huang
Gennady Shvets
Nagireddy Putluri
Jenny Li
Xuefeng Liu
author_sort Abdalla Elbialy
collection DOAJ
description Prostate cancer exhibits significant racial disparities, with African American (AA) individuals showing ∼64% higher incidence and 2.3 times greater mortality rates compared to their Caucasian (CA) counterparts. Understanding the complex interplay of genetic, environmental, lifestyle, socioeconomic, and healthcare access factors is crucial for developing effective interventions to reduce this disproportionate burden.This study aims to uncover the genetic and transcriptomic differences driving these disparities through a comprehensive analysis using RNA sequencing (RNA-seq) and exome sequencing of prostate cancer tissues from both Black and White patients.Our transcriptomics analysis revealed enhanced activity in pathways linked to immune response and cellular interactions in AA prostate cancer samples, with notable regulation by histone-associated transcription factors (HIST1H1A, HIST1H1D, and HIST1H1B) suggests potential involvement of histone modification mechanisms. Additionally, pseudogenes and long non-coding RNAs (lncRNAs) among the regulated genes indicate non-coding elements' role in these disparities.Exome sequencing identified unique variants in AA patient samples within key genes, including TP73 (tumor suppression), XYLB (metabolism), ALDH4A1 (oxidative stress), PTPRB (cellular signaling), and HLA-DRB5 (immune response). These genetic variations likely contribute to disease progression and therapy response disparities.This study highlights the importance of considering genetic and epigenetic variations in developing tailored therapeutic approaches to improve treatment efficacy and reduce mortality rates across diverse populations.
format Article
id doaj-art-3594846d1d2840a8ba850dcf32fd28be
institution OA Journals
issn 2772-8927
language English
publishDate 2025-04-01
publisher Elsevier
record_format Article
series Cell Insight
spelling doaj-art-3594846d1d2840a8ba850dcf32fd28be2025-08-20T02:16:02ZengElsevierCell Insight2772-89272025-04-014210023810.1016/j.cellin.2025.100238Unveiling racial disparities in prostate cancer using an integrative genomic and transcriptomic analysisAbdalla Elbialy0Akshay Sood1Shang-Jui Wang2Peng Wang3Ahmed Fadiel4Anil V. Parwani5Steven Huang6Gennady Shvets7Nagireddy Putluri8Jenny Li9Xuefeng Liu10OSU Comprehensive Cancer Center, The Ohio State University, Columbus, OH, 43210, USA; Computational Oncology Unit, The University of Chicago Comprehensive Cancer Center, 900 E 57th Street, KCBD Bldg., STE 4144, Chicago, IL, 60637, USAOSU Comprehensive Cancer Center, The Ohio State University, Columbus, OH, 43210, USA; Department of Urology, College of Medicine, The Ohio State University, Columbus, OH, 43210, USAOSU Comprehensive Cancer Center, The Ohio State University, Columbus, OH, 43210, USA; Department of Radiation Oncology, College of Medicine, The Ohio State University, Columbus, OH, 43210, USAOSU Comprehensive Cancer Center, The Ohio State University, Columbus, OH, 43210, USA; Department of Medicine, College of Medicine, The Ohio State University, Columbus, OH, 3210, USAComputational Oncology Unit, The University of Chicago Comprehensive Cancer Center, 900 E 57th Street, KCBD Bldg., STE 4144, Chicago, IL, 60637, USAOSU Comprehensive Cancer Center, The Ohio State University, Columbus, OH, 43210, USA; Departments of Pathology, College of Medicine, The Ohio State University, Columbus, OH, 43210, USASchool of Applied and Engineering Physics, Cornell University, Ithaca, NY, 14850, USASchool of Applied and Engineering Physics, Cornell University, Ithaca, NY, 14850, USADepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, 77030, USAOSU Comprehensive Cancer Center, The Ohio State University, Columbus, OH, 43210, USA; Departments of Pathology, College of Medicine, The Ohio State University, Columbus, OH, 43210, USAOSU Comprehensive Cancer Center, The Ohio State University, Columbus, OH, 43210, USA; Departments of Pathology, Urology, and Radiation Oncology, College of Medicine, The Ohio StateUniversity, Columbus, OH, 43210, USA; Corresponding author. OSU Comprehensive Cancer Center, The Ohio State University, Columbus, OH, 43210, USA.Prostate cancer exhibits significant racial disparities, with African American (AA) individuals showing ∼64% higher incidence and 2.3 times greater mortality rates compared to their Caucasian (CA) counterparts. Understanding the complex interplay of genetic, environmental, lifestyle, socioeconomic, and healthcare access factors is crucial for developing effective interventions to reduce this disproportionate burden.This study aims to uncover the genetic and transcriptomic differences driving these disparities through a comprehensive analysis using RNA sequencing (RNA-seq) and exome sequencing of prostate cancer tissues from both Black and White patients.Our transcriptomics analysis revealed enhanced activity in pathways linked to immune response and cellular interactions in AA prostate cancer samples, with notable regulation by histone-associated transcription factors (HIST1H1A, HIST1H1D, and HIST1H1B) suggests potential involvement of histone modification mechanisms. Additionally, pseudogenes and long non-coding RNAs (lncRNAs) among the regulated genes indicate non-coding elements' role in these disparities.Exome sequencing identified unique variants in AA patient samples within key genes, including TP73 (tumor suppression), XYLB (metabolism), ALDH4A1 (oxidative stress), PTPRB (cellular signaling), and HLA-DRB5 (immune response). These genetic variations likely contribute to disease progression and therapy response disparities.This study highlights the importance of considering genetic and epigenetic variations in developing tailored therapeutic approaches to improve treatment efficacy and reduce mortality rates across diverse populations.http://www.sciencedirect.com/science/article/pii/S2772892725000124Racial disparitiesProstate cancerGenomicsTranscriptomicsEtiologyDifferential analysis
spellingShingle Abdalla Elbialy
Akshay Sood
Shang-Jui Wang
Peng Wang
Ahmed Fadiel
Anil V. Parwani
Steven Huang
Gennady Shvets
Nagireddy Putluri
Jenny Li
Xuefeng Liu
Unveiling racial disparities in prostate cancer using an integrative genomic and transcriptomic analysis
Cell Insight
Racial disparities
Prostate cancer
Genomics
Transcriptomics
Etiology
Differential analysis
title Unveiling racial disparities in prostate cancer using an integrative genomic and transcriptomic analysis
title_full Unveiling racial disparities in prostate cancer using an integrative genomic and transcriptomic analysis
title_fullStr Unveiling racial disparities in prostate cancer using an integrative genomic and transcriptomic analysis
title_full_unstemmed Unveiling racial disparities in prostate cancer using an integrative genomic and transcriptomic analysis
title_short Unveiling racial disparities in prostate cancer using an integrative genomic and transcriptomic analysis
title_sort unveiling racial disparities in prostate cancer using an integrative genomic and transcriptomic analysis
topic Racial disparities
Prostate cancer
Genomics
Transcriptomics
Etiology
Differential analysis
url http://www.sciencedirect.com/science/article/pii/S2772892725000124
work_keys_str_mv AT abdallaelbialy unveilingracialdisparitiesinprostatecancerusinganintegrativegenomicandtranscriptomicanalysis
AT akshaysood unveilingracialdisparitiesinprostatecancerusinganintegrativegenomicandtranscriptomicanalysis
AT shangjuiwang unveilingracialdisparitiesinprostatecancerusinganintegrativegenomicandtranscriptomicanalysis
AT pengwang unveilingracialdisparitiesinprostatecancerusinganintegrativegenomicandtranscriptomicanalysis
AT ahmedfadiel unveilingracialdisparitiesinprostatecancerusinganintegrativegenomicandtranscriptomicanalysis
AT anilvparwani unveilingracialdisparitiesinprostatecancerusinganintegrativegenomicandtranscriptomicanalysis
AT stevenhuang unveilingracialdisparitiesinprostatecancerusinganintegrativegenomicandtranscriptomicanalysis
AT gennadyshvets unveilingracialdisparitiesinprostatecancerusinganintegrativegenomicandtranscriptomicanalysis
AT nagireddyputluri unveilingracialdisparitiesinprostatecancerusinganintegrativegenomicandtranscriptomicanalysis
AT jennyli unveilingracialdisparitiesinprostatecancerusinganintegrativegenomicandtranscriptomicanalysis
AT xuefengliu unveilingracialdisparitiesinprostatecancerusinganintegrativegenomicandtranscriptomicanalysis